Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Allergan
|
| gptkbp:acquired |
gptkb:Abb_Vie
|
| gptkbp:acquisition |
gptkb:2020
|
| gptkbp:employees |
approximately 50,000
|
| gptkbp:founded |
gptkb:1983
|
| gptkbp:founder |
gptkb:Dr._J._Michael_Bishop
|
| gptkbp:headquarters |
gptkb:United_States
gptkb:Irvine,_California |
| https://www.w3.org/2000/01/rdf-schema#label |
Allergan Medical
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:known_for |
gptkb:skincare_product
ophthalmic products injectables surgical products dermatology products |
| gptkbp:parent_company |
gptkb:Abb_Vie_Inc.
|
| gptkbp:products |
gptkb:Botox
|
| gptkbp:revenue |
$15.8 billion (2020)
|
| gptkbp:specializes_in |
neuroscience
ophthalmology urology gastroenterology medical aesthetics |
| gptkbp:website |
www.allergan.com
|